This RSA section is an unofficial mirror, is not legal advice, and may be incomplete, outdated, or incorrectly processed.
RSA 318-B:2-b · Counterfeit Drugs; Affirmative Defense
318-B:2-b Counterfeit Drugs; Affirmative Defense. – It is an affirmative defense to prosecution under RSA 318-B:2, I-a that the actor is: I. A physician or advanced practice registered nurse who sells, dispenses, or prescribes a substance which he represents to be or contain a controlled drug, but which in fact neither is nor contains a controlled drug, to a patient under his care for a bona fide therapeutic purpose; or II. A pharmacist who sells or dispenses a substance which he represents to be or contain a controlled drug, but which in fact neither is nor contains a controlled drug, to a person at the direction of and upon the written prescription of an attending physician or advanced practice registered nurse, provided any written prescription is properly executed, dated, and signed by the person prescribing on the day when issued and bears the full name and address of the patient for whom the drug is dispensed; or III. A nurse or intern who, at the explicit direction of and under the supervision of an attending physician, administers a substance which he represents to be or contain a controlled drug, but which in fact neither is nor contains a controlled drug, to a patient for a bona fide therapeutic purpose; or IV. An advanced emergency medical care provider who, upon receipt directly or by phone or by radio or by other communication medium of directions to do so from the supervising physician or an emergency/trauma advanced practice registered nurse, administers a substance which he represents to be or to contain a controlled drug, but which in fact neither is nor contains a controlled drug, to a patient for a bona fide therapeutic purpose. Source. 1983, 36:2. 1992, 48:7. 1994, 333:20. 2009, 54:5, eff. July 21, 2009.
Source note
Source. 1983, 36:2. 1992, 48:7. 1994, 333:20. 2009, 54:5, eff. July 21, 2009.
Source history
- 1983, 36:2
- 1992, 48:7
- 1994, 333:20
- 2009, 54:5, eff. July 21, 2009
Related materials
Bills affecting or mentioning this RSA
- 2026 HB1235-FN reference
- 2026 HB1237 reference
- 2026 HB1423-FN amend · 2027-01-01
- 2026 HB1796-FN reference · 2027-01-01
- 2026 HB186-FN-A amend
- 2026 HB194-FN reference · 2027-01-01
- 2026 SB465-FN amend · 2027-01-01
- 2026 SB467-FN reference · 2027-01-01
- 2026 SB485-FN reference · 2027-01-01
- 2026 SB504-FN reference · 2027-01-01
- 2026 SB624-FN amend · 2027-01-01
- 2026 SB651-FN-A amend